Reduction in tumor proliferation and increase in apoptosis was observed after inhibiting the COX and 5-LOX pathways in high MYC mice, highlighting these pathways as potential drug targets for lung adenocarcinoma [46]. This evidence concerns the gene MYC and lung adenocarcinoma.